ALNYLAM PHARMACEUTICALS, INC. Total Operating Expenses 2008-2025 | ALNY
What is total operating expenses?
Total operating expenses include all costs related to running the core business, including cost of goods sold, R&D, and SG&A.
What is ALNYLAM PHARMACEUTICALS, INC.'s current total operating expenses?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual total operating expenses for 2025 was $3.21B, a 32.46% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. total operating expenses for the quarter ending December 31, 2025 was $965.3M.
What was ALNYLAM PHARMACEUTICALS, INC.'s total operating expenses in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual total operating expenses for 2024 was $2.43B, a 14.91% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s total operating expenses in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual total operating expenses for 2023 was $2.11B, a 15.80% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year total operating expenses CAGR?
ALNYLAM PHARMACEUTICALS, INC. total operating expenses grew at a compound annual growth rate (CAGR) of 19.44% from FY2020 to FY2025, going from $1.32B to $3.21B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.21B | +32.5% | 10-K |
| FY2024 | $2.43B | +14.9% | 10-K |
| FY2023 | $2.11B | +15.8% | 10-K |
| FY2022 | $1.82B | +17.4% | 10-K |
| FY2021 | $1.55B | +17.5% | 10-K |
| FY2020 | $1.32B | +14.0% | 10-K |
| FY2019 | $1.16B | +30.3% | 10-K |
| FY2018 | $889.6M | +50.8% | 10-K |
| FY2017 | $590.0M | +25.1% | 10-K |
| FY2016 | $471.7M | +39.9% | 10-K |
| FY2015 | $337.1M | -26.0% | 10-K |
| FY2014 | $455.5M | +225.1% | 10-K |
| FY2013 | $140.1M | -28.6% | 10-K |
| FY2012 | $196.2M | +42.6% | 10-K |
| FY2011 | $137.6M | -4.5% | 10-K |
| FY2010 | $144.1M | -3.0% | 10-K |
| FY2009 | $148.6M | +19.9% | 10-K |
| FY2008 | $124.0M | - | 10-K |